Growth Hormone in EB

• Conditions: Epidermolysis Bullosa Dystrophica

• Registration Number: NCT05390073
• Lead Sponsor: Cairo University

Brief Summary

Growth is extremely affected in epidermolysis bullosa patients

Detailed Description

Studying the role of growth hormone and ILGF-1 in EB may pave the to new therapeutic modality that could improve the growth in those children and avoid the irreversible sequelae that affected subjects experience after adulthood

Study Timeline

• Status Verified: 2022-05
• Study First Submitted: 2022-05-20
• Study First Submitted QC: 2022-05-24
• Last Update Submitted: 2022-05-24
• Study Start: 2022-05-25
• Study First Posted: 2022-05-25
• Last Update Posted: 2022-05-25
• Primary Completion: 2022-06-10
• Study Completion: 2022-06-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Children with EB dystrophica

Exclusion Criteria

• Adults with the same disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
level of growth hormone and insulin like growth factor 1	2 weeks	laboratory test